Brazil
Egypt
Europe
Hong Kong
Malaysia
Mexico
Morocco
Philippines
Saudi Arabia
South Africa
Taiwan
Thailand
Tunisia
Turkey
UAE
USA
Vietnam
Global HQ
Press Releases 2016
Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data
- Tue, 27-Dec-2016
- Posted by: Biocon Biologics
No Comments
Biocon Features in Asia IP Elite 2016 List
- Fri, 09-Dec-2016
- Posted by: Biocon Biologics
Biocon’s Novel Diabetes Education Initiative for Medical Practitioners ‘ABIDE’ Awarded by RSSDI
- Tue, 29-Nov-2016
- Posted by: Biocon Biologics
Biocon Collaborates with Healthcare Professionals for a Public Awareness Campaign on Diabetes Prevention & Management Across India
- Fri, 11-Nov-2016
- Posted by: Biocon Biologics
Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab
- Tue, 08-Nov-2016
- Posted by: Biocon Biologics
Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency
- Thu, 03-Nov-2016
- Posted by: Biocon Biologics
Biocon Ranked Among Global Top Ten Biotech Employers; The only Asian Company to Feature in 2016 Rankings Biocon moves up to No. 9 from No. 13 last year
- Fri, 28-Oct-2016
- Posted by: Biocon Biologics
Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45%; Revenues at Rs 992 Crs.; EBITDA at Rs 277 Crs.; Net Profit at Rs 147 Crs.
- Thu, 20-Oct-2016
- Posted by: Biocon Biologics
Kiran Mazumdar Shaw Appointed ‘Knight of the Legion of Honour’ by the Government of France
- Thu, 01-Sep-2016
- Posted by: Biocon Biologics
Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency
- Thu, 21-Jul-2016
- Posted by: Biocon Biologics
- 1
- 2
